Mallinckrodt Said to Work With Bank to Seek Nuclear Unit Bidders

  • Pharmaceutical company working with adviser on sale options
  • Private equity firms understood to be among interested parties

Drugmaker Mallinckrodt Plc is working with advisers to seek potential buyers for its nuclear imaging division, according to people familiar with the matter.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.